← back to database
DaVita Venture Group builds and strategically invests in healthcare companies improving kidney care, with priorities spanning new care models, technology-enabled services, digital health, pharmaceuticals, medical devices and adjacent clinical services.
Specialization
Generalist / Specialist
Specialist
Investing team
Brad MarzulloVice President, Corporate Development, Venture Capital, and Partnerships
Mahesh KrishnanGroup Vice President, DaVita Venture Group
Nick RolfesSenior Director, Venture Capital
Will TonelliManager, Venture Capital
Notable investments
Egenesis, Greater Good Health, Wellth, Dock Health, Vynca, Xeltis, Pathalys, R1 Therapeutics, Miromatrix, Samesky Health